Varicose veins Circulatory System Varicose veins of lower extremities
Conditions
Interventions
1. Recruitment:
Patients will be recruited from outpatient clinics held at the Queen Elizabeth Hospital and Freeman Hospital. Three patient groups, determined by the anatomical site of venous reflux w
Sponsors
Gateshead Health NHS Foundation Trust (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients with long or short saphenous venous reflux 2. Patients with varicose veins belonging to any of the clinical classes of Clinical, Etiologic, Anatomic and Pathophysiologic (CEAP) classification C2, C3, C4, C5 and C6 3. Patients with a full range of movement of the joints in both their lower limbs 4. Patients who are freely mobile with no mechanical aid assisting their movement 5. Aged 18 - 75
Exclusion criteria
Exclusion criteria: 1. Patients belonging to CEAP Ec, Po and Po & R or with past history of Deep Vein Thrombosis (DVT) or pulmonary embolism 2. A history suggestive of deep venous obstruction 3. Peripheral arterial disease 4. Anticoagulation therapy 5. Serious systemic diseases such as angina, myocardial infarction, asthma, COAD, CCF, hepatic failure and renal failure 6. Pregnancy 7. Any patent with heparin allergy 8. Patients unable to give consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To quantify and assess the venous pressure-lowering effect of Foam Sclerotherapy in patients with lower limb superficial venous reflux and to compare the venous pressures with patients' activity profiles. These measurements will be performed using a Continuous Ambulatory Venous Pressure Monitoring device and a NUMACT system | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess changes in quality of life associated with foam sclerotherapy treatments using the Aberdeen Varicose Vein Questionnaire. | — |
Countries
United Kingdom
Outcome results
None listed